Annual Current Liabilities
$47.09 M
+$22.70 M+93.05%
December 31, 2021
Summary
- As of February 9, 2025, TPTX annual total current liabilities is $47.09 million, with the most recent change of +$22.70 million (+93.05%) on December 31, 2021.
- During the last 3 years, TPTX annual current liabilities has risen by +$41.77 million (+784.80%).
Performance
TPTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$49.42 M
+$3.86 M+8.46%
June 30, 2022
Summary
- As of February 9, 2025, TPTX quarterly total current liabilities is $49.42 million, with the most recent change of +$3.86 million (+8.46%) on June 30, 2022.
- Over the past year, TPTX quarterly current liabilities has stayed the same.
Performance
TPTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TPTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +93.0% | 0.0% |
| 3 y3 years | +784.8% | 0.0% |
| 5 y5 years | +940.6% | 0.0% |
TPTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -7.8% |
| 5 y | 5-year | at high | -70.2% | at high | -77.4% |
| alltime | all time | at high | -90.4% | at high | -89.2% |
Turning Point Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $49.42 M(+8.5%) |
| Mar 2022 | - | $45.57 M(-3.2%) |
| Dec 2021 | $47.09 M(+93.1%) | $47.09 M(+21.5%) |
| Sep 2021 | - | $38.75 M(+21.5%) |
| Jun 2021 | - | $31.89 M(+30.9%) |
| Mar 2021 | - | $24.37 M(-0.1%) |
| Dec 2020 | $24.39 M | $24.39 M(+20.4%) |
| Sep 2020 | - | $20.26 M(+76.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $11.45 M(+2.6%) |
| Mar 2020 | - | $11.15 M(-20.5%) |
| Dec 2019 | $14.03 M(+163.7%) | $14.03 M(+19.7%) |
| Sep 2019 | - | $11.72 M(+48.6%) |
| Jun 2019 | - | $7.89 M(-2.9%) |
| Mar 2019 | - | $8.12 M(+52.6%) |
| Dec 2018 | $5.32 M(+17.6%) | $5.32 M |
| Dec 2017 | $4.53 M | - |
FAQ
- What is Turning Point Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Turning Point Therapeutics?
- What is Turning Point Therapeutics annual current liabilities year-on-year change?
- What is Turning Point Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Turning Point Therapeutics?
- What is Turning Point Therapeutics quarterly current liabilities year-on-year change?
What is Turning Point Therapeutics annual total current liabilities?
The current annual current liabilities of TPTX is $47.09 M
What is the all time high annual current liabilities for Turning Point Therapeutics?
Turning Point Therapeutics all-time high annual total current liabilities is $47.09 M
What is Turning Point Therapeutics annual current liabilities year-on-year change?
Over the past year, TPTX annual total current liabilities has changed by +$22.70 M (+93.05%)
What is Turning Point Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of TPTX is $49.42 M
What is the all time high quarterly current liabilities for Turning Point Therapeutics?
Turning Point Therapeutics all-time high quarterly total current liabilities is $49.42 M
What is Turning Point Therapeutics quarterly current liabilities year-on-year change?
Over the past year, TPTX quarterly total current liabilities has changed by $0.00 (0.00%)